[caption id="attachment_3457" align="aligncenter" width="270"] Question answered by:Gregory K. Harmon, MDBoard Chairman of The Glaucoma Foundation[/caption] Blood pressure and eye pressure vary independently. Controlling blood pressure does not mean IOP is controlled. But studies have shown that patients with high blood pressure have an increased risk for glaucoma. Very high blood pressure is not good for glaucoma. Moderate to very low blood
Author: Andrea Steele
How to Qualify for Social Security Disability Benefits with Glaucoma
Glaucoma is a serious eye condition. It’s the number one cause of blindness and it can strike people who are as young as 40, even though it’s primarily thought of as something that affects mainly seniors. The fact is that more than a million people are diagnosed with glaucoma each year and for many of those people glaucoma makes it
Low Tech – High Tech: LOW VISION SOLUTIONS 101
Please join us and our panel of low-vision specialists and patient advocates for a live webinar with Q&A on May 27, Low Tech - High Tech: LOW VISION SOLUTIONS 101. We will be talking about a range of techniques and assets you can use to improve your home and work-life from simple low-tech methods and products to advanced optical and
TGF and RPB Announce New Grants
Research to Prevent Blindness and The Glaucoma Foundation Offer Critical Funding for Early-Career Vision Scientists NEW YORK, NY, April 14, 2021—Research to Prevent Blindness is pleased to announce a new round of grants, the Career Advancement Awards (CAAs), that support early-career researchers as they seek new knowledge related to eye diseases. The Award is aimed at early- to mid-career
New Grant Topic Announced
Forecasting Glaucoma Disease Progression with Artificial Intelligence MAJOR GAPS IN GLAUCOMA CARE: We currently have no way to forecast glaucoma disease progression or make predictions about whether patients will require incisional surgery or be blinded by glaucoma. Also, decisions about target IOP are arbitrary and based on clinical consideration of patient age, amount of baseline damage, and baseline IOP. The Glaucoma Foundation (TGF)
Ways to Look and Feel Your Best in 2021
[caption id="attachment_3261" align="aligncenter" width="300"] Photo Credit: Pexels[/caption] We’re coming out of a challenging year. Although vaccine distribution provides a light at the end of the tunnel, we still have a ways to go. Whether you’re stuck at home or safely navigating the world, it’s important to find ways to look and feel your best. These forms of self-care can give
New Fellowships Support Under-Represented Minorities in Glaucoma Research
The Glaucoma Foundation and Research to Prevent Blindness have partnered to provide five fellowships in 2021 to increase innovation and diversity in glaucoma research. NEW YORK, March 10, 2021 – The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit
Update on Home Tonometry: An Easy Way to Track Your IOP
TGF invites you to learn about "MyEYES" Please join us on Tuesday, March 9, 2021 - 5 pm EDT MyEYES is dedicated to helping you better manage your glaucoma with access to the personal tonometer, iCare HOME. Click Here to Register Medical devices that are required for testing or diagnostics are often prohibitively expensive and sometimes hard to access. In
“Bringing the Latest Glaucoma Science Directly to the Patient” – A Live Online Seminar with Q&A
On Saturday, February 27, 2021 from 10 am to noon Eastern Daylight Time on ZOOM, The Glaucoma Foundation will present an online seminar with two Q&A sessions, “Bringing the Latest Glaucoma Science Directly to the Patient.” Click Here to Register Four experts will discuss issues of importance to glaucoma patients, clinicians and researchers including advances in glaucoma diagnosis and treatment
Clinical Glaucoma Trials
Nearly all treatments, including drugs and medical devices, require clinical trials and approval by the government’s Food and Drug Administration (FDA). The journey from a scientific breakthrough to a treatment you can access is a long one -- taking years. (The recent approvals of COVID-19 vaccines are welcome exceptions to that timeframe.) A clinical trial is a research study using